Eli Lilly has announced encouraging results from its late-stage Phase 3 clinical trial of retatrutide, an investigational next-generation obesity treatment that delivered dramatic weight reduction in adults living with obesity or overweight conditions.

The Central Drugs Standard Control Organisation (CDSCO) has issued a public notice clarifying that cosmetic products cannot be used through injections and are not permitted for treatment purposes under Indian law.

The notice, released by the Directorate General of Health Services under the Ministry of Health and Family Welfare, comes amid rising use of aesthetic and beauty procedures in clinics and salons across the country.

A promising targeted therapy may offer new hope to children and adults living with fibrous dysplasia, a rare bone disorder that weakens bones and severely affects mobility. Researchers have reported that the drug burosumab significantly improved phosphate balance and physical function in patients suffering from the debilitating condition.